Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study.
Front Immunol
; 12: 815812, 2021.
Article
in English
| MEDLINE | ID: covidwho-1834392
ABSTRACT
[This corrects the article DOI 10.3389/fimmu.2021.709861.].
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Front Immunol
Year:
2021
Document Type:
Article
Affiliation country:
Fimmu.2021.815812
Similar
MEDLINE
...
LILACS
LIS